Besides the morphine-antagonist naloxone, the central dopamine antagonist haloperidol has also been tested, presenting this peptide's close interaction with the dopamine system (11, 15-17, 19)
In the control group, an equivalent amount of saline was used
Some of these claims have clinical grounding, while others stretch the evidence considerably
Most people tolerate NAD+ injections well, but some side effects can occur
Such developments would provide researchers with an expanded toolkit for investigating the complex relationships between metabolism, aging, and disease, potentially accelerating discoveries across multiple fields of biomedical research
The answer is yes